Literature DB >> 7054321

Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis.

J D Band, J I Ward, D W Fraser, N J Peterson, V A Silcox, R C Good, P R Ostroy, J Kennedy.   

Abstract

Two outbreaks of peritonitis caused by a Mycobacterium chelonei-like organism--a previously unrecognized pathogen--occurred among patients receiving intermittent chronic peritoneal dialysis (CPD). In one center, five of 22 patients who had undergone CPD during a one-month period developed peritonitis caused by an M. chelonei-like organism acquired from a single contaminated automated CPD machine. In a second center, five of eight patients who had received CPD during a several-week period became infected, apparently as a result of cross-infection from contaminated machines. Seven sporadic cases of peritonitis due to an M. chelonei-like organism were also found. M. chelonei-like organisms can survive and proliferate in water and are relatively resistant to formaldehyde. Defects in the design of CPD machines and disinfection procedures were identified that may have permitted M. chelonei-like organisms to survive attempted disinfection.

Entities:  

Mesh:

Year:  1982        PMID: 7054321     DOI: 10.1093/infdis/145.1.9

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.

Authors:  G L Woods; J S Bergmann; F G Witebsky; G A Fahle; B Boulet; M Plaunt; B A Brown; R J Wallace; A Wanger
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 3.  Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.

Authors:  Kevin L Winthrop; Michael Iseman
Journal:  Nat Rev Rheumatol       Date:  2013-06-25       Impact factor: 20.543

Review 4.  Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.

Authors:  R J Wallace
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 5.  Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review.

Authors:  M Kunin; A Knecht; E J Holtzman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-26       Impact factor: 3.267

6.  Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism.

Authors:  R J Wallace; V A Silcox; M Tsukamura; B A Brown; J O Kilburn; W R Butler; G Onyi
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.

Authors:  B A Brown; R J Wallace; G Onyi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

9.  PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.

Authors:  V A Steingrube; J L Gibson; B A Brown; Y Zhang; R W Wilson; M Rajagopalan; R J Wallace
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Fatal granulomatous meningoencephalitis associated to mycobacterium mucogenicum-like microorganism: a case report.

Authors:  Carlos A Sariol; Yussef Galib; Petraleigh Pantoja; Lillian Colón; Anarda González; Lee Marie Tormos; Jorge Santana; Carlos A Luciano; Janis González-Martínez; Edmundo N Kraiselburd
Journal:  P R Health Sci J       Date:  2009-09       Impact factor: 0.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.